Sionna Therapeutics, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -5.8% | +99.0% | -4.8% | -3.6% | -3.9% | -6.4% | -7.1% | |
| – | – | – | – | +7.6% | +81.3% | -2.5% | -5.4% | -4.3% | -8.5% | -2.2% | |
| – | – | – | – | +5.7% | +118.8% | -50.4% | +24.0% | +15.0% | +8.3% | 0.0% | |
| – | – | – | – | +7.3% | +82.8% | -2.6% | -5.4% | -5.0% | -8.4% | -2.4% | |
| – | – | – | – | +1.1% | -94.9% | -12.8% | +12.7% | +8.6% | -12.0% | +3.8% | |
| – | – | – | – | +60.9% | -8.6% | -20.8% | +30.5% | +18.9% | -16.5% | +10.3% | |
| – | – | – | – | +4.4% | +4.4% | +4.4% | +4.2% | +4.3% | +4.2% | +4.2% | |
| – | – | – | – | +1,040.4% | +323.2% | -81.8% | +62.0% | -48.1% | +174.3% | -75.2% | |
| – | – | – | – | – | – | -4.4% | -4.4% | -4.6% | -6.1% | -7.8% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | -0.1% | +0.1% | +0.8% | -10.1% | +12.4% | +0.5% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.